Navigation Links
OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
Date:7/23/2012

SAN DIEGO, July 23, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB:ONCS), a company developing the advanced-stage OncoSec Medical System (OMS) ElectroOncology therapies to treat solid tumors, announced data from an interim analysis of two randomized Phase III clinical trials, HNBE-01 and HNBE-02, using electrochemotherapy to treat locally recurrent and second primary squamous cell carcinoma of the head and neck (SCCHN). The data are being presented July 22-24 at the 8th International Conference on Head and Neck Cancer in Toronto, Canada. A link to the abstract can be found here: http://ahns.jnabstracts.com/Detail.aspx?ID=0778

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

In these studies, electrochemotherapy was compared against surgery for quality of life, safety, survival and local control at eight months, where local control is defined as destruction of the treated tumor without evidence of reappearance of the tumor at the treatment site. The data show OMS ElectroChemotherapy achieved the primary endpoint of preserving quality of life compared to surgery, and appears to be safe and comparable to surgery in achieving control in locally recurrent or second primary SCCHN. This therapy represents a viable alternative to potentially major surgical interventions for this patient population, where recurrent tumors in SCCHN usually have a poor prognosis with a local control rate of 40-50 percent and frequently associated loss of organ function.

Paul Goldfarb, M.D., Consulting Medical Director of OncoSec overseeing the Phase III studies, said, "Despite the early termination of this study, delayed interim analysis of these data clearly demonstrated there was equivalence in safety, local control at eight months and survival between electrochemotherapy and surge
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
6. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
7. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
10. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015   Symbiomix Therapeutics , a ... for serious women,s health infections, today announced results ... its lead product candidate, SYM-1219, was safe and ... that contraceptive efficacy for birth control pills would ... These results will be presented on March 6 ...
(Date:3/3/2015)... 2015  The packaging industry plays a major ... provides containment and drug safety but also ensures ... patent loss delivers more generics into the market, ... turn encouraging low-cost innovation in emerging markets. The ... the pharmaceutical packaging industry towards low-cost, sustainable and ...
(Date:3/3/2015)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical solutions ... at the 27 th Annual ROTH Conference, which is ... California from March 8 to March 11. ... , will be presenting on Monday, March 9 at 12:00 ... , the company,s Vice President of Finance and Chief Accounting ...
Breaking Medicine Technology:Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 3Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 4Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 5Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... 8, 2010 George Products Company, Inc. has announced ... of its OASIS Inspection Systems. Florida ... southeast Florida. OASIS Inspection Systems is a line of ... to quality control departments across the United States. Tim ...
... 1st to the 3rd of March 2011, vaccine leaders ... World Summit in New Delhi. The event will be ... Vaccine Manufacturers Network). Participants will be discussing ... pandemic surveillance programs, low cost and fast vaccine manufacturing ...
Cached Medicine Technology:Florida Metrology To Distribute OASIS Inspection Systems 2World Vaccine Leaders to Meet in New Delhi India to Tackle Global Public Health Challenges 2
(Date:3/4/2015)... Nike Swim Camps offer outstanding coaching by ... to stimulate a love of swimming in a positive ... the opportunity to train with some of the most ... President of US Sports Camps. “Our program directors provide ... confidence and improve their technique.” , Nike Swim Camp ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... therapeutics market is driven by the increasing incidence of ... encouraging pipeline of late stage drugs. The unmet medical ... fore the untapped potential in the market. Presently, there ... drugs that overcome the limitations of current generation drugs. ...
(Date:3/4/2015)... Ohio (PRWEB) March 04, 2015 Nitrosigine®, ... an ingredient in premium sports nutrition products, is hosting ... Trainer booth in the Terrace Ballroom at The Arnold ... from March 5, 2015 to March 8, 2015. ... silicate with FDA New Dietary Ingredient notification status; now ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the appearance of the skin and body, are witnessing ... therapeutic agents to achieve the desired product properties and ... obsessed with physical beauty, youth, and achievement. Demand for ... sales of cosmetics. Growth in the market is driven ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, ... for Vasculitis. Vasculitis is a disease that features tenderness ... diseases is not known. Vasculitis can affect any body ... Symptoms can include fever, weight loss, tiredness, aches, pains, ... a limb. Vasculitis is treatable, but it is not ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4
... University of Utah researchers in the development and testing of ... would transmit the nerve impulses from nerves in the residual ... then to the bionic arm. This will facilitate the person ... ,Sensors placed in the artificial arm will be designed ...
... ocean currents in climate change and the story behind Antarctica’s ... to be holding the clue. ,An element pretty ... teeth has offered a clue to the University of Florida ... Atlantic and Pacific might have opened up. This has happened ...
... Administration is being prompted by the Drug Manufacturer, Wyeth ... hormone drugs to treat menopause.// The drugs are made ... approved. ,Following Wyeth's recommendation to the FDA, the ... on these custom-made treatments, and have requested the agency ...
... Functional and structural difference in the brain can explain ... in unique ways to the effects// of certain pain-relief ... Georgia State University and the Atlanta-based Center for Behavioral ... conducted on rat brains, the results highlight that similar ...
... a report by the Food and Agriculture Organisation (FAO) of ... animal species said that domestic and wild birds spread the ... accumulated since the start of the avian influenza crisis (the ... in the transmission of the virus in the natural setting. ...
... and as a clean up drive legalisation of drugs is ... free drugs to addicts// to help clean up the Downtown ... Sam Sullivan a donation by an anonymous donor of $500,000 ... ,The reason and goal behind this whole exercise would be ...
Cached Medicine News:Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: